Elekta (OTCMKTS:EKTAY) Releases Quarterly Earnings Results

Elekta (OTCMKTS:EKTAY) posted its earnings results on Thursday. The company reported $0.09 EPS for the quarter, Zacks reports. The company had revenue of $433.29 million during the quarter. Elekta had a net margin of 1.62% and a return on equity of 12.14%.

Elekta Stock Up 10.6%

Shares of EKTAY traded up $0.64 during midday trading on Friday, hitting $6.69. 370 shares of the company’s stock traded hands, compared to its average volume of 2,686. The company has a current ratio of 1.04, a quick ratio of 0.79 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $2.47 billion, a price-to-earnings ratio of 95.60 and a beta of 1.07. Elekta has a 1 year low of $4.35 and a 1 year high of $6.93. The firm’s fifty day moving average is $6.29 and its 200-day moving average is $5.58.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.